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ouston, Texas
OBJECTIVES We sought to characterize the clinical nature of atrial flutter (AFL) in a large cohort of
infants.
BACKGROUND There are no large studies describing the natural history of AFL in infants. Previous studies
vary in the therapy used and expected prognosis.
METHODS We reviewed the records of all children younger than 1 year of age who were diagnosed with
AFL at our hospital during the past 25 years, excluding those with previous cardiac surgery.
RESULTS We identified 50 infants with AFL. Most, 36 (72%), presented within the first 48 h of life.
Congestive heart failure was evident in 10 infants, with 6 presenting at 1 day of age, and 4
presenting beyond 1 month of age. The remainder were asymptomatic. A large atrial septal
defect was the only structural heart disease. Spontaneous conversion to sinus rhythm occurred
in 13 (26%) infants. Sinus rhythm was restored in 20 of 23 (87%) attempts at direct current
cardioversion and 7 of 22 (32%) attempts at transesophegeal pacing; 7 required antiarrhyth-
mic therapy. An additional arrhythmia, all supraventricular, appeared in 11 (22%) infants.
The recurrence of AFL developed in 6 infants; 5 of 6 of these incidents occurred within 24 h
of the first episode. All patients with recurrence had an additional arrhythmia.
CONCLUSIONS Infants with AFL usually present within the first 2 days of life. No association was found with
structural heart disease. Direct current cardioversion appears to be most effective at
establishing sinus rhythm. Chronic AFL has the potential to cause cardiovascular compro-
mise. Atrial flutter in the absence of other arrhythmias has a low risk of recurrence. Once in
sinus rhythm, infants with AFL have an excellent prognosis and may not require chronic
antiarrhythmic therapy. (J Am Coll Cardiol 2006;48:1040–6) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.091College of Cardiology Foundation
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strial flutter (AFL) is an uncommon arrhythmia in new-
orns and infants. The low incidence of AFL in this age
roup makes it difficult to study, and previous reports vary as
o the most efficacious therapy and expected prognosis
1–9). These previous studies were limited by small, non-
niform patient populations. The purpose of this study was
o characterize the natural history of AFL in a large cohort
f infants, including presentation, therapy, and prognosis.
ETHODS
nclusion criteria. We identified all infants younger than
ne year of age who presented to Texas Children’s Hospital
ith AFL during the previous 25 years. All patients had
FL documented by a standard electrocardiogram (ECG)
nd confirmed by a pediatric cardiologist at Texas Chil-
ren’s Hospital (Fig. 1). Infants with previous cardiac
urgery were excluded. When AFL was diagnosed by the
se of fetal echocardiogram, it was not included unless the
rrhythmia persisted after birth and was documented as
escribed.
ata collection. Data were obtained by retrospective chart
eview of all infants 1 year of age or younger with a diagnosis
f AFL. All medical records from our hospital were queried,
From the Department of Pediatrics, Division of Cardiology, Texas Children’s
ospital, Baylor College of Medicine, Houston, Texas. Supported by the American
ediatric Society, Society for Pediatric Research, The Woodlands, Texas.t
Manuscript received July 14, 2005; revised manuscript received April 7, 2006,
ccepted April 11, 2006.ncluding Texas Children’s Hospital inpatient records, the
ardiology Clinic computerized database, and the comput-
rized log of ECGs performed. Clinical information col-
ected included age at diagnosis, signs and symptoms at
resentation, method of conversion to sinus rhythm, and
edications. Prenatal and birth histories also were reviewed.
he ECG features analyzed were rate of AFL, atrioventric-
lar conduction ratio, recurrence, and the development of
dditional arrhythmias. Echocardiographic data were re-
iewed, including intracardiac anatomy, the presence of
trial dilation, and ventricular function. All ECGs, 24 h
olter monitors, echocardiogram results, and follow-up
linic visits were reviewed.
tatistical analysis. Descriptive statistics were used to
haracterize ECG and clinical features. Differences in con-
inuous variables were compared using a two-tailed t test.
he Fisher exact test was used in evaluating proportions
etween categorical variables. Statistical significance was
efined as a p value of less than 0.05. Data was analyzed
sing SISA (Quantitative Skills, Hilversum, the Nether-
ands), on Internet Explorer version 6.0 (Microsoft Corpo-
ation, Redmond, Washington).
ESULTS
ge and presentation. We identified 52 infants with AFL
n the first year of life with no history of previous cardiac
urgery. Two patients were excluded—1 infant with persis-
ent fetal circulation and a large clot at the tip of an
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September 5, 2006:1040–6 Atrial Flutter in Infantsmbilical venous catheter, and 1 infant who developed AFL
n the postoperative period after lung resection with umbil-
cal lines in place. Of the remaining 50 infants, there were
1 boys and 19 girls. The majority, 36 (72%), presented in
FL within the first 48 h of life; 29 at birth, 5 on day of life
DOL) 1, and 2 on DOL 2. A prenatal diagnosis of AFL
ad been made in 2 of these infants. An additional 8 infants
resented before they were 1 month of age, and 6 presented
eyond the first month of age, up to 210 days of life (Fig. 2).
The majority of patients (40 of 50, 80%) presented with
symptomatic tachycardia noted on routine examination
nd monitoring. Ten infants (20%) presented with conges-
ive heart failure and depressed ventricular function, as
ssessed by echocardiogram. Six infants presented in AFL at
irth with cardiac compromise, including 5 infants with
evere hydrops. Four infants presented with symptomatic
ongestive heart failure outside of the newborn period—1 at
weeks of life with a patent ductus arteriosus and large
trial septal defect and 3 with normal intracardiac anatomy
ho developed symptomatic heart failure when they were
lder than 3 months of life (Fig. 2). Infants who presented
eyond 3 months of age were statistically more likely to
Abbreviations and Acronyms
AFL  atrial flutter
DC CV  direct current cardioversion
DOL  day of life
ECG  electrocardiogram/electrocardiographic
SVT  supraventricular tachycardia
TEP  transesophageal pacingFigure 1. Twelve-lead electrocardiogram showing sawtooth patevelop congestive heart failure (p  0.035). Most patients
33 of 50, 66%) had a single episode of AFL, were
symptomatic, and easily converted to sinus rhythm. Sev-
nteen patients (34%) had AFL complicated by congestive
eart failure, recurrence, an additional arrhythmia, or AFL
hat was refractory to conversion to sinus rhythm. These
atients are listed in Table 1 as “Infants With Complicated
trial Flutter.”
Infants with congestive heart failure were of 2 groups. Of
hose presenting symptomatic on DOL 1, 5 of 6 were noted
o be in tachycardia in utero at 36 to 40 weeks of gestation,
rompting delivery by induced vaginal delivery or Cesarean.
ive of these newborns had either AFL that was refractory
igure 2. Age at presentation for infants with atrial flutter, distinguishing
nfants who were asymptomatic or with symptoms of congestive heart
ailure (CHF) secondary to atrial flutter.tern of atrial flutter with 2:1 atrioventricular conduction.
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Atrial Flutter in Infants September 5, 2006:1040–6o multiple attempts at conversion or developed an addi-
ional arrhythmia requiring treatment (Patient #1, #2, #3,
4, and #6). The sixth newborn was converted to sinus
hythm by a single attempt at direct current cardioversion
DC CV) and had no further recurrences. The remaining
our symptomatic infants presented with symptoms outside
f the newborn period after development of congestive heart
ailure. Of these 4, 2 had AFL that was difficult to convert
o sinus rhythm (Patient #8 and #10), and 1 infant had a
arge atrial septal defect and patent ductus arteriosus (Pa-
ient #7). She subsequently had resolution of congestive
eart failure symptoms after restoring sinus rhythm.
CG features. The diagnosis of AFL was made by a
urface ECG in all patients. The mean rate of AFL was
24  46 beats/min (range 340 to 580 beats/min). Mean
entricular response rate was 208  28 beats/min (range
25 to 280 beats/min) (Fig. 3). Atrioventricular conduction
ssessed by ECG was 2:1 in 75% and was variable in the
emaining episodes. No statistical differences were found in
CG features between those who responded well to treat-
ent, developed additional arrhythmias, became symptom-
tic, or had a recurrence of AFL.
chocardiographic features. All infants had a structurally
ormal heart by echocardiogram except for 1 patient, who
ad an atrial septal defect and patent ductus arteriosus. She
resented at 5 weeks of age with congestive heart failure,
able 1. Characteristics of Infants With Complicated Atrial Flut
Patient
Age at
Diagnosis (Days) CHF
Additional
Arrhythmias C
1 1 Yes SVT TE
2 1 Yes AFIB TE
3 1 Yes SVT Fa
Fle
Am
4 1 Yes SVT, WPW Fa
Qu
5 1 Yes — CV
6 1 Yes — Fa
Pro
7 35 Yes
PDA, ASD
CV
8 84 Yes — Fa
CV
9 90 Yes — CV
10 125 Yes — Fa
Pro
11 1 — AET Fa
Am
12 1 — SVT Fa
Pro
13 1 — AET Sp
14 11 — SVT Fle
15 1 — SVT TE
16 1 — AET Fa
Sp
17 16 — SVT TE
ET  atrial ectopic tachycardia; AFIB  atrial fibrillation; ASD  atrial septal de
uctus arteriosus; TEP  transesophageal pacing; SR  sinus rhythm; SVT  supras converted to sinus rhythm by DC CV, treated for heart wailure, and was then lost to follow-up. She represented at 5
ears of age with cardiomegaly and subsequently underwent
urgical ligation of her patent ductus arteriosus and closure
f her atrial septal defect. Cardiomegaly improved, and she
as had no recurrence of arrhythmia. Ventricular function
as depressed in 10 infants (20%), as shown by decreased
hortening fraction on echocardiogram, and was normal in
he remaining 40 infants. After restoration of sinus rhythm,
ll instances of ventricular dysfunction resolved within a
atter of weeks. No patients in the study group had
vidence of atrial thrombus formation.
Atrial dilation was a common finding, observed in 18 of
0 infants (36%). No relationship was found among atrial
ilation and flutter rate, atrioventricular conduction ratio,
he presence of an additional arrhythmia, or flutter recur-
ence. Of 18 patients with atrial dilation, only 2 had
ignificant atrioventricular valve regurgitation, which was
oderate in both cases. Of note, atrial dilation was present
n all patients with ventricular dysfunction and was related
o a later age at presentation. The mean age at presentation
or patients without atrial dilation was 6 days, whereas for
atients with atrial dilation, the mean age was 31 days,
lthough result did not reach statistical significance, with a
value of 0.1. This suggests the atrial dilation may have
esulted from the combination of 2 factors seen in patients
sponse to
rsion Attempts Recurrence Maintenance Medications
— Digoxin, propranolol
Yes Digoxin
EP
e SR
rone SR
Yes Digoxin, amiodarone
V 6
e SR
— Quinidine, digoxin
— Digoxin
EP, CV
mide SR
— No follow-up
— Digoxin
EP — Digoxin
— Quinidine, digoxin
V 3,
olol SR
— Propranolol
EP, CV
rone SR
Yes Amiodarone, propranolol, digoxin
EP and CV
mide  CV SR
Yes Flecainide, digoxin
eous SR — Sotalol, digoxin
e SR Yes Flecainide, digoxin
— Propranolol, digoxin
EP
eous SR
Yes Flecainide, digoxin
— No follow-up
HF  congestive heart failure; CV  direct current cardioversion; PDA  patent
icular tachycardia; WPW Wolff-Parkinson-White syndrome.ter
Re
onve
P SR
P SR
iled T
cainid
ioda
iled C
inidin
SR
iled T
caina
SR
iled T
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iled C
pran
iled T
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iled T
caina
ontan
cainid
P SR
iled T
ontan
P SRith a longer duration of tachycardia—the chronic loss of
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September 5, 2006:1040–6 Atrial Flutter in Infantstrioventricular synchrony, and the development of ventric-
lar dysfunction after prolonged tachycardia.
onversion to sinus rhythm. All patients successfully
onverted to sinus rhythm either spontaneously or by
ntervention with DC CV, transesophageal pacing (TEP),
nd/or antiarrhythmic drugs. Outcomes of each method of
onversion are shown in Figure 4. Twenty infants were
ltimately converted by DC CV (20 of 23 attempts; 87%),
nd 7 infants were converted to sinus rhythm by TEP (7 of
2 attempts; 32%). Two infants developed atrial fibrillation
uring attempts at TEP, which reverted spontaneously to
inus rhythm. There were no other complications due to
EP or cardioversion. Spontaneous conversion to sinus
hythm occurred in 13 infants. All infants who converted
pontaneously did so within a few hours of the diagnosis.
Pharmacologic therapy was instituted in 15 infants.
welve received digoxin loading as first-line therapy. Sinus
hythm occurred in 4 infants within hours of beginning the
igoxin load; the remaining eight required additional inter-
igure 3. (A) Rate of atrial flutter. (B) Ventricular rate during atrial flutter.
pm  beats/min.ention. Seven infants received antiarrhythmic treatment becondary to refractory AFL that persisted despite multiple
ttempts at conversion (Table 1) (Patient #3, #4, #6, #10,
11, #12, and #14). Patient #3 had successful control of the
FL but developed ventricular tachycardia while on flecain-
de; the flecainide was then changed to amiodarone. Patient
10 converted to sinus rhythm after 2 weeks on propranolol.
atient #12 was converted to sinus rhythm by DC CV after
oading with procainamide and is included in the successful
C CV group. Of patients requiring antiarrhythmic ther-
py, 1 responded to amiodarone, 1 to flecainide, 1 to
miodarone and flecainide combined, 2 to procainamide,
nd 1 each to quinidine and propranolol.
All infants with symptomatic heart failure underwent
rompt intervention to restore sinus rhythm, 5 with initial
ttempts by DC CV and 5 with TEP. Three of these
atients were successfully DC cardioverted, and 2 were
uccessfully overdrive paced. There were 3 failed initial
ttempts at TEP, 2 of whom were successfully cardioverted.
hree patients ultimately failed multiple attempts to restore
inus rhythm and required antiarrhythmic therapy.
ecurrence and long-term prognosis. Six infants (12%)
xperienced a recurrence of AFL (Table 1). One infant had
single recurrent episode (Patient #16), 2 had two recur-
ences (Patient #2 and #11), and three experienced multiple
ecurrent episodes of AFL that required antiarrhythmic
herapy to control (Patient #3, #12, and #14). The AFL
ecurred within 24 h of termination in 5 of 6 instances, and
infant had a later recurrence of AFL 5 days after his initial
pisode. There were no recurrences of AFL outside of this
-day period, including over long-term follow-up (mean
uration of 27 months for the 41 patients in whom
ollow-up data was available).
Eleven infants (22%) had a second arrhythmia in addition
o AFL. These included supraventricular tachycardia (SVT)
7 patients), atrial ectopic tachycardia (3 patients), and atrial
brillation (1 patient) (Table 1). One patient had evidence
f pre-excitation, which was not evident during tachycardia.
n 9 of 11 instances, the additional arrhythmia developed
ithin 48 h of presentation with AFL (range 1 to 8 days).
n infants with an additional arrhythmia, the recurrence rate
f AFL was 63% (6 of 11). All infants with a recurrence of
FL had an additional arrhythmia. Of the 39 infants without
n additional arrhythmia, none had a recurrence. This result
epresented a statistically increased risk of recurrence over
nfants without an additional arrhythmia (p  0.001).
atients with AFL that was refractory to conversion to sinus
hythm also were more likely to demonstrate an additional
rrhythmia (p  0.005). An additional arrhythmia occurred
n 4 of the 6 patients with refractory AFL who required
ntiarrhythmic medication (Table 1).
Of patients who developed SVT, 1 had an isolated
pisode of atrial fibrillation, 6 had frequent nonsustained
pisodes of SVT in the first few days of life that required
ontinued drug therapy, and 1 had persistent SVT through-
ut the first month of life, which ultimately was controlled
y amiodarone. None have had recurrence of SVT in late
f
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Atrial Flutter in Infants September 5, 2006:1040–6ollow-up. The 3 patients with atrial ectopic tachycardia
AET) had incessant tachycardia throughout the newborn
eriod. Patient 1 had persistent AET throughout the first
eek of life until being administered flecainide; this patient
xperienced no further recurrences over the course of 5 years.
atient 13 was treated with sotalol and converted to sinus
hythm at 6 weeks of age. He did well until having a recurrence
f AET at the age of 7 years. Patient #11 was able to achieve
ate control only with amiodarone, propranolol, and digoxin,
ut was stable in AET until converting to sinus rhythm at
ix months of age, after which he had no further recurrence
hrough follow-up to 16 months of age.
Of the 50 infants, 41 (82%) underwent follow-up at
exas Children’s Hospital Cardiology Clinic. Maintenance
edications were given to 36 of the 41 infants observed in
ollow-up; 5 received no medications. Antiarrhythmic drugs
ther than digoxin (flecainide, propranolol, sotalol, quini-
ine, and amiodarone) were used as chronic therapy in 11
nfants. Of these 11 infants, 9 had an additional arrhythmia
hat required continued therapy, 1 was treated with pro-
ranolol after failing conversion attempts at DC CV, and 1
as treated with quinidine once in sinus rhythm after
resenting in congestive heart failure. Once sinus rhythm
as established, no patient had a recurrence of AFL during
ong-term follow up outside of the early recurrences de-
Figure 4. Conversion of atrial flutter to sinus rhythm in 50 infantcribed previously. Of the 5 infants who did not receive ahronic therapy, none had a recurrence. All cases of de-
reased ventricular function resolved within weeks of restor-
ng sinus rhythm, as documented by repeat echocardiogram.
ISCUSSION
his study is the largest to date of infants younger than one
ear of age with AFL. In general, AFL in infants is a
ell-tolerated arrhythmia, despite the often great atrial and
entricular rates. The rate of AFL in our population of
nfants was more rapid than that typically seen in adults
ith AFL, up to 580 beats/min, with rapid ventricular
esponse rates, up to 280 beats/min. The diagnosis can be
ade from the surface ECG, which most frequently dem-
nstrates 2:1 or variable atrioventricular conduction. Similar
o previous studies, we found no association between infant
FL and structural congenital heart disease (4,5,9). By
esign, our study excluded infants with a history of previous
ardiac surgery to study the nature of AFL in native
yocardium, unaltered by scar formation. Despite the low
ncidence of structural heart disease, obtaining an echocar-
iogram can be useful to evaluate ventricular function
ecause a significant number of infants did have ventricular
ysfunction.
The potential exists, however, for cardiac compromise
 direct current cardioversion; TEP  transesophageal pacing.nd the development of congestive heart failure. The devel-
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September 5, 2006:1040–6 Atrial Flutter in Infantspment of symptoms did not correlate with rapid atrial or
entricular rates or conduction ratio but appeared to be
elated to the duration of the tachycardia, which is consis-
ent with the findings of Naheed et al. (10) and Martin and
ernandez (7). Of the 10 infants who presented with
ymptoms of congestive heart failure, all had a history
ompatible with prolonged tachycardia. Infants who were
ymptomatic were of 2 groups. Of those 6 presenting
ymptomatic on DOL 1, 5 were noted to be in tachycardia
n utero at 36 to 40 weeks of gestation, prompting delivery
y induced vaginal delivery or Cesarean. Five of the 6
ontinued with persistent tachycardia after birth; 3 had
ultiple recurrences of AFL, 4 had an additional arrhyth-
ia, and 1 had AFL refractory to multiple attempts at
ardioversion until the addition of procainamide. The re-
aining four presented outside of the newborn period after
he development of symptoms of congestive heart failure.
hese 2 groups share a common potential mechanism for
he development of ventricular dysfunction in that both
ikely had prolonged periods of tachycardia before detection,
ither before birth or after discharge from the nursery until
he development of symptoms.
We found DC CV and TEP to be safe methods to
ttempt restoration of sinus rhythm. There was a low
ncidence of atrial fibrillation during attempts at TEP, and
o complications from DC CV were observed. Direct
urrent cardioversion appeared more successful than TEP at
stablishing sinus rhythm. However, our conversion rate for
EP was lower than previously reported (5,11,12). In this
etrospective study, without data available regarding pacing
rotocols, we are unable to compare the effectiveness of
hese 2 modalities. A prospective study would be better
uited to compare the efficacy of DC CV versus TEP for
onversion of AFL.
tudy limitations. One of the limitations faced in this study
elates to the wide range of time periods during which study
atients were treated, during which the management strat-
gies were not uniform. Across patients in this study, the
nitial attempts at conversion were more commonly TEP;
owever, an approximately equal number of patients ulti-
ately underwent attempts at DC CV and TEP. A number
f infants spontaneously converted to sinus rhythm before
nitial attempts at conversion, as well as a small number who
ailed repeated attempts at electrical conversion and re-
uired antiarrhythmic medications. Overall, infants with
ymptomatic heart failure underwent prompt intervention
o restore sinus rhythm; none of these infants converted to
inus rhythm spontaneously. This result likely represents a
ore urgent triage of symptomatic infants to undergo
mmediate intervention, as well as potentially a more per-
istent state of tachycardia resulting in the development of
ymptoms, that was less likely to convert spontaneously.
Spontaneous conversion to sinus rhythm occurred in 13
26%) infants. Although exact data on the time of conver-
ion to sinus rhythm were not available, all reverted to sinus
hythm within 24 h of diagnosis. We also saw conversion of tof the 12 infants who received digoxin therapy initially,
nd all converted within hours of receiving the first dose.
lthough previously the use of digoxin has been supported
s initial therapy for pharmacologic conversion (2), its
fficacy has been brought into question based on the widely
ariable time between the initiation of digoxin therapy and
onversion to sinus rhythm (5,7). It may be argued that the
patients who converted after receiving digoxin therapy in
ur study may have actually done so spontaneously. We
gree with those authors who, based on efficacy, do not
ecommend digoxin as a first-line therapy for conversion to
inus rhythm (3,5,7). Electrical conversion by DC CV is the
ost effective method to establish sinus rhythm, although in
he asymptomatic infant, a waiting period of 6 to 12 h may
e considered, given the possibility of spontaneous conver-
ion. In symptomatic infants, we recommend prompt use of
C CV.
The presence of an additional arrhythmia was the only
tatistically significant factor identified for recurrent and
efractory AFL. Additional supraventricular arrhythmias
ppear to be fairly frequent (22%). Infants with an addi-
ional arrhythmia had a significantly increased risk of
ecurrence of AFL, and of having AFL that was refractory
o attempts at conversion. When either a recurrence of AFL
r an additional arrhythmia occurred, it was most likely to
e evident within 48 h of termination of the first episode
nd was unlikely beyond 72 h. Previous reports have shown
n association between AFL and the presence of accessory
athways (8). In our patient population, only one infant had
vidence of pre-excitation, which was not manifested during
FL. Given the frequency of re-entrant SVT in our patient
opulation (7 of 50, 14%) and that the most likely mechanism
n this age group is an accessory pathway, one might even
peculate an association of AFL with concealed pathways.
Chronic maintenance therapy was given to most of the
nfants. Most received digoxin, whereas those with an
dditional arrhythmia or refractory AFL received other
ntiarrhythmic medications. The fact that the majority
eceived therapy makes it difficult to assess the need for
hronic drug therapy in these infants. However, in our more
ecent experience with five infants who did not receive any
aintenance therapy, none had a recurrence, suggesting
hat in infants with uncomplicated, asymptomatic AFL who
onvert spontaneously or respond easily to electrical conver-
ion to sinus rhythm, maintenance therapy may not be
ecessary.
Atrial flutter remains a rare tachycardia in the newborn
nd young infant and usually presents in the newborn period
ith asymptomatic tachycardia. Congestive heart failure
ay develop and appears to be most related to the duration
f the tachycardia. Isolated AFL in a newborn does not
uggest an underlying structural heart defect, even if signs or
ymptoms of congestive heart failure are present. Infants
ith AFL respond well to DC CV but may convert to sinus
hythm spontaneously. On occasion, AFL may be refractory
o attempts at electrical cardioversion or have recurrences
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Atrial Flutter in Infants September 5, 2006:1040–6equiring the use of antiarrhythmic medications. Addi-
ional supraventricular arrhythmias, if present, greatly
ncrease the risk for the recurrence of AFL. In the
bsence of additional arrhythmias, infants with AFL have
n excellent prognosis once in sinus rhythm with a low
isk of recurrence, and chronic antiarrhythmic therapy is
nlikely to be necessary.
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